This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Roberts, J A Articles by Svenson, S B Search for Related Content PubMed PubMed Citation Articles by Roberts, J A Articles by Svenson, S B

 Previous Article  |  Next Article 

Infect Immun. 1993 December; 61(12): 5214-5218

Prevention of renal scarring from pyelonephritis in nonhuman primates by vaccination with a synthetic Escherichia coli serotype O8 oligosaccharide-protein conjugate.

Department of Urology, Tulane University School of Medicine, New Orleans, Louisiana 70112.

ABSTRACT

Rhesus monkeys were vaccinated with a synthetic Escherichia coli serotype O8 oligosaccharide-protein conjugate. Using our experimental pyelonephritis monkey model, we tested whether such immunization was protective against the renal damage from inflammation following experimental infection with a P-fimbriated O-antigenically homologous E. coli strain. The vaccination did not significantly alter the duration of bacteriuria or interfere with the infection. However, the vaccine was efficient in renal protection, as vaccinated animals showed significantly less intratubular infiltration of neutrophils (P < 0.02) and the degree of renal scarring was also significantly less in these animals (P > 0.005) than in the control animals. Total kidney involvement in the vaccinated animals was 16.9%, compared with 32.5% in the control animals (P = 0.07).

This article has been cited by other articles:

• Flanagan, M.P., Battisti, G., Michael, J.G. (1996). Oral administration of Escherichia coli in enteric coated microparticles induces serum antibodies against lipopolysaccharide antigens. Innate Immunity 3: 481-489 [Abstract]